RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+22.28%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$307M
AUM Growth
+$307M
(-3.6%)
Cap. Flow
-$54.4M
Cap. Flow
% of AUM
-17.71%
Top 10 Holdings %
Top 10 Hldgs %
77.5%
Holding
46
New
3
Increased
17
Reduced
6
Closed
8
Top Buys
| 1 |
Omeros
OMER
|
$20.9M |
| 2 |
Atara Biotherapeutics
ATRA
|
$4.51M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$3.74M |
| 4 |
KITE
Kite Pharma, Inc.
KITE
|
$2.68M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$2.68M |
Top Sells
| 1 |
Incyte
INCY
|
$33.5M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$19M |
| 3 |
Arrowhead Research
ARWR
|
$12.1M |
| 4 |
BLUE
bluebird bio
BLUE
|
$9.38M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$6.48M |
Sector Composition
| 1 | Healthcare | 79.07% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$58.5B
| $54M | 17.56% | 573,361 +39,701 | +7% | +$3.74M |
|
|
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $29.3M | 9.53% | 1,084,416 +4,085 | +0.4% | +$110K |
|
|
3
Omeros
OMER
$283M
| $28.6M | 9.31% | 1,819,341 +1,329,341 | +271% | +$20.9M |
|
|
KITE
4
DELISTED
Kite Pharma, Inc.
KITE
| $25.8M | 8.4% | 418,935 +43,459 | +12% | +$2.68M |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $23.9M | 7.77% | 2,012,662 +7,424 | +0.4% | +$88.1K |
|
|
ACHN
6
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $21.5M | 6.98% | 1,988,914 -600,904 | -23% | -$6.48M |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $20.7M | 6.75% | 2,010,501 -217,705 | -10% | -$2.25M |
|
|
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $12.2M | 3.96% | 385,456 -96,613 | -20% | -$3.05M |
|
|
9
Atara Biotherapeutics
ATRA
$84.6M
| $11.5M | 3.73% | 433,923 +170,928 | +65% | +$4.51M |
|
|
FPRX
10
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $10.7M | 3.47% | 257,236 -456,718 | -64% | -$19M |
|
|
AGEN
11
Agenus
AGEN
$133M
| $10.1M | 3.27% | 2,214,453 +130,311 | +6% | +$592K |
|
12
Celldex Therapeutics
CLDX
$1.47B
| $9.99M | 3.25% | 637,238 -81,491 | -11% | -$1.28M |
|
|
SSRG
13
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $8.09M | 2.63% | 879,623 +72,181 | +9% | +$664K |
|
14
Bristol-Myers Squibb
BMY
$96B
| $7.55M | 2.45% | 109,701 +7,276 | +7% | +$500K |
|
|
CORI
15
DELISTED
Corium International, Inc.
CORI
| $6.04M | 1.97% | 743,865 +168,653 | +29% | +$1.37M |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.66M | 1.84% | 175,156 +82,757 | +90% | +$2.68M |
|
|
DYAX
17
DELISTED
DYAX CORPORATION
DYAX
| $4.36M | 1.42% | 115,795 +437 | +0.4% | +$16.4K |
|
18
Regenxbio
RGNX
$451M
| $3.67M | 1.2% | 221,326 +16,832 | +8% | +$279K |
|
19
Lipocine
LPCN
$15.8M
| $2.85M | 0.93% | 220,515 +8,018 | +4% | +$104K |
|
|
AXDX
20
DELISTED
Accelerate Diagnostics
AXDX
| $2.31M | 0.75% | +107,467 | New | +$2.31M |
|
|
IVTY
21
DELISTED
Invuity, Inc
IVTY
| $1.79M | 0.58% | 202,808 +27,808 | +16% | +$245K |
|
22
Masimo
MASI
$7.59B
| $1.08M | 0.35% | 25,900 | – | – |
|
23
Anika Therapeutics
ANIK
$135M
| $1.05M | 0.34% | +27,500 | New | +$1.05M |
|
|
MDRX
24
DELISTED
Veradigm Inc. Common Stock
MDRX
| $738K | 0.24% | 48,000 | – | – |
|
|
TMBR
25
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $563K | 0.18% | 370,636 | – | – |
|